As of close of business last night, ProQR Therapeutics N.V.’s stock clocked out at $2.90, down -7.94% from its previous closing price of $3.15. In other words, the price has decreased by -$0.2500 from its previous closing price. On the day, 1170318 shares were traded. PRQR stock price reached its highest trading level at $3.1500 during the session, while it also had its lowest trading level at $2.8500.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
To gain a deeper understanding of PRQR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.90 and its Current Ratio is at 3.90. In the meantime, Its Debt-to-Equity ratio is 0.34 whereas as Long-Term Debt/Eq ratio is at 0.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Cantor Fitzgerald on December 22, 2022, Upgraded its rating to Overweight and sets its target price to $5 from $0.80 previously.
On February 14, 2022, Citigroup Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $37 to $1.70.
Stifel Downgraded its Buy to Hold on February 11, 2022, whereas the target price for the stock was revised from $20 to $3.
For the stock, the TTM Price-to-Sale (P/S) ratio is 43.59 while its Price-to-Book (P/B) ratio in mrq is 2.93.
Stock Price History:
Over the past 52 weeks, PRQR has reached a high of $6.15, while it has fallen to a 52-week low of $0.53. The 50-Day Moving Average of the stock is 2.4130, while the 200-Day Moving Average is calculated to be 1.2054.
It appears that PRQR traded 3.01M shares on average per day over the past three months and 1.12M shares per day over the past ten days. A total of 71.38M shares are outstanding, with a floating share count of 62.46M. Insiders hold about 20.89% of the company’s shares, while institutions hold 42.20% stake in the company. Shares short for PRQR as of Oct 13, 2022 were 1.25M with a Short Ratio of 1.85M, compared to 349.55k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 1.75% and a Short% of Float of 1.86%.
As of right now, 6 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.21 for the current quarter, with a high estimate of -$0.17 and a low estimate of -$0.25, while EPS last year was -$0.25. The consensus estimate for the next quarter is -$0.19, with high estimates of -$0.14 and low estimates of -$0.25.
Analysts are recommending an EPS of between -$0.73 and -$0.95 for the fiscal current year, implying an average EPS of -$0.84. EPS for the following year is -$0.69, with 6 analysts recommending between -$0.37 and -$1.05.
A total of 8 analysts have provided revenue estimates for PRQR’s current fiscal year. The highest revenue estimate was $5.95M, while the lowest revenue estimate was $2.48M, resulting in an average revenue estimate of $3.85M. In the same quarter a year ago, actual revenue was $2.59M, up 48.60% from the average estimate.